These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 9457926)
1. Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group. Coelingh Bennink HJ; Fauser BC; Out HJ Fertil Steril; 1998 Jan; 69(1):19-25. PubMed ID: 9457926 [TBL] [Abstract][Full Text] [Related]
2. Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic,chronic anovulation: a prospective randomized study. Yarali H; Bukulmez O; Gurgan T Fertil Steril; 1999 Aug; 72(2):276-81. PubMed ID: 10438995 [TBL] [Abstract][Full Text] [Related]
3. Ovulation induction with low dose alternate day recombinant follicle stimulating hormone (Puregon). Buckler HM; Robertson WR; Anderson A; Vickers M; Lambert A Hum Reprod; 1999 Dec; 14(12):2969-73. PubMed ID: 10601080 [TBL] [Abstract][Full Text] [Related]
4. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial. Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878 [TBL] [Abstract][Full Text] [Related]
5. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome. Bayram N; van Wely M; van Der Veen F Cochrane Database Syst Rev; 2001; (2):CD002121. PubMed ID: 11406034 [TBL] [Abstract][Full Text] [Related]
6. A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon((R))) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP((R))) in a fixed-dose regimen in women undergoing ovarian stimulation. Hoomans EH; Andersen AN; Loft A; Leerentveld RA; van Kamp AA; Zech H Hum Reprod; 1999 Oct; 14(10):2442-7. PubMed ID: 10527965 [TBL] [Abstract][Full Text] [Related]
7. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens. van Santbrink EJ; Fauser BC J Clin Endocrinol Metab; 1997 Nov; 82(11):3597-602. PubMed ID: 9360513 [TBL] [Abstract][Full Text] [Related]
8. A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome. Homburg R; Levy T; Ben-Rafael Z Fertil Steril; 1995 Apr; 63(4):729-33. PubMed ID: 7890055 [TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Out HJ; Mannaerts BM; Driessen SG; Bennink HJ Hum Reprod; 1995 Oct; 10(10):2534-40. PubMed ID: 8567765 [TBL] [Abstract][Full Text] [Related]
10. Urofollitropin and ovulation induction. van Wely M; Yding Andersen C; Bayram N; van der Veen F Treat Endocrinol; 2005; 4(3):155-65. PubMed ID: 15898821 [TBL] [Abstract][Full Text] [Related]
11. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone. Hoffman DI; Lobo RA; Campeau JD; Tsai HM; Holmberg EA; Ono T; Frederick JJ; Platt LD; diZerega GS J Clin Endocrinol Metab; 1985 May; 60(5):922-7. PubMed ID: 3920235 [TBL] [Abstract][Full Text] [Related]
12. Ovulation induction in women with polycystic ovary syndrome: randomized trial of clomiphene citrate versus low-dose recombinant FSH as first line therapy. López E; Gunby J; Daya S; Parrilla JJ; Abad L; Balasch J Reprod Biomed Online; 2004 Oct; 9(4):382-90. PubMed ID: 15511336 [TBL] [Abstract][Full Text] [Related]
13. Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements. Homburg R; Howles CM Hum Reprod Update; 1999; 5(5):493-9. PubMed ID: 10582786 [TBL] [Abstract][Full Text] [Related]
14. Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency. Imani B; Eijkemans MJ; Faessen GH; Bouchard P; Giudice LC; Fauser BC Fertil Steril; 2002 Jan; 77(1):83-90. PubMed ID: 11779595 [TBL] [Abstract][Full Text] [Related]
15. Relationship of baseline ovarian volume to ovarian response in World Health Organization II anovulatory patients who underwent ovulation induction with gonadotropins. Lass A; Vassiliev A; Decosterd G; Warne D; Loumaye E Fertil Steril; 2002 Aug; 78(2):265-9. PubMed ID: 12137861 [TBL] [Abstract][Full Text] [Related]
16. [Ovulation induction with pure FSH in anovulatory patients resistant to clomifene citrate]. Kably-Ambe A; Reyes-Cuervo H; Barrón-Vallejo J Ginecol Obstet Mex; 1996 Jul; 64():293-6. PubMed ID: 8756188 [TBL] [Abstract][Full Text] [Related]
17. Clomiphene citrate co-treatment with low dose urinary FSH versus urinary FSH for clomiphene resistant PCOS: randomized controlled trial. Ghanem ME; Elboghdady LA; Hassan M; Helal AS; Gibreel A; Houssen M; Shaker ME; Bahlol I; Mesbah Y J Assist Reprod Genet; 2013 Nov; 30(11):1477-85. PubMed ID: 24014214 [TBL] [Abstract][Full Text] [Related]
18. [Chronic low dose follicle stimulating hormone step-up regimen in the treatment of polycystic ovary syndrome related anovulatory infertility with clomiphene resistance]. Chen W; Zhang Y; Dai Q Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):588-90. PubMed ID: 11372406 [TBL] [Abstract][Full Text] [Related]
19. Induction of ovulation with the use of a starting dose of 50 units of recombinant human follicle-stimulating hormone (Puregon). Hayden CJ; Rutherford AJ; Balen AH Fertil Steril; 1999 Jan; 71(1):106-8. PubMed ID: 9935125 [TBL] [Abstract][Full Text] [Related]
20. Clomifene citrate or low-dose FSH for the first-line treatment of infertile women with anovulation associated with polycystic ovary syndrome: a prospective randomized multinational study. Homburg R; Hendriks ML; König TE; Anderson RA; Balen AH; Brincat M; Child T; Davies M; D'Hooghe T; Martinez A; Rajkhowa M; Rueda-Saenz R; Hompes P; Lambalk CB Hum Reprod; 2012 Feb; 27(2):468-73. PubMed ID: 22128296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]